© Royal College of Physicians of Edinburgh, 2007. Should you wish to print or quote parts of, or the whole of, this statement, prior permission must be secured from Graeme McAlister, Head of Communications and Publishing, Royal College of Physicians of Edinburgh, 9 Queen Street, Edinburgh, EH2 1JQ. Telephone 0131 247 3693; Fax 0131 226 6124; Email: g.mcalister@rcpe.ac.uk
UK Consensus Conference on Early Chronic Kidney Disease
| The first 10% of the full text of this article appears below. |
Authors/members of Consensus Panel: Archibald G, Bartlett W, Brown A, Christie B, Elliott A, Griffith K, Pound S, Rappaport I, Robertson D, Semple Y, Slane P, Whitworth C and Williams B (Chair).
Detection of adults with early chronic kidney disease (CKD) is important because some will progress to end-stage kidney disease and most are at higher risk of premature cardiovascular disease. Early identification provides the greatest opportunity to modify the course of disease and the associated cardiovascular risk.
| What is early CKD? |
|---|
An international classification of CKD has identified five stages. Early CKD is described as stages 1–3. Stages 1 and 2 are characterized by: structural abnormalities, presence of persistent proteinuria or albuminuria or haematuria. Stage 3 is characterized by impaired kidney function as defined by estimated
| Improving detection of early CKD |
|---|
Estimating GFR
| Improving classification of early CKD |
|---|
| Improving organization of care |
|---|
| Clinical recommendations |
|---|
Lifestyle
Blood pressure
Cardiovascular risk management
Bone mineral disorders
Anaemia
Medicines management
Research